c-MET-mediated resistance to EGFR inhibitors in head and neck cancer: How to move from bench to bedside.
Department of Oncology, Bichat-Beaujon University Hospital, Paris, France; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: szturz@gmail.com.
Petr
P
Szturz
Department of Oncology, Bichat-Beaujon University Hospital, Paris, France.
Eric
E
Raymond
Department of Oncology, Bichat-Beaujon University Hospital, Paris, France.
Sandrine
S
Faivre
D000970:Antineoplastic Agents; D002294:Carcinoma, Squamous Cell; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D066246:ErbB Receptors; D006258:Head and Neck Neoplasms; D006801:Humans; D047428:Protein Kinase Inhibitors; D019859:Proto-Oncogene Proteins c-met
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors; D019859:Proto-Oncogene Proteins c-met